Axyntis Centipharm (Grasse) employs 60 people and has 116 cubic metres of reaction volume. The site is audited and certified by the ANSM. It contains an R&D laboratory, pilot workshop, multi-use synthesis workshops and a cGMP finishing unit. The site specialises in the production of intermediates and pharmaceutical active ingredients, including 30 generic substances with regulatory support (Drug Master File and CEP). It also produces specialist chemical intermediates. Centipharm is ISO 14001 certified.